| [1] | Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. | 
																													
																							| [2] | Rook GA,Dalgleish A. Infection,immunoregulation,and cancer[J]. Immunol Rev, 2011, 240(1):141-159. | 
																													
																							| [3] | Chaturvedi VK, Singh A, Dubey SK, et al. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma[J]. Microb Pathog, 2019, 128(3):184-194. | 
																													
																							| [4] | Yu LX, Schwabe RF. The gut microbiome and liver cancer; mechanisms and clinical translation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(9):527-539. | 
																													
																							| [5] | Zhou TY, Zhou YL, Qian MJ, et al. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages[J]. J Pharmacol Sci, 2018, 138(2):89-95. | 
																													
																							| [6] | Zhou X, Li W, Wang S, et al. YAP aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis[J]. Cell Rep, 2019, 27(4):1176-1189, e5. | 
																													
																							| [7] | Wang Z, Yan M, Li J,et al. Dual functions of STAT3 in LPS-induced angiogenesisof hepatocellular carcinoma[J]. Biochim Biophys Acta Mol Cell Res, 2019, 1866(4):566-574. | 
																													
																							| [8] | Dong YQ, Lu CW, Zhang L,et al. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway[J]. Mol Immunol, 2015, 68(2 Pt C):671-683. | 
																													
																							| [9] | Lu Y, Xu J, Chen S, et al. Lipopolysaccharide promotes angiogenesis in mice model of HCC by stimulating hepatic stellate cell activation via TLR4 pathway[J]. Acta Biochim Biophys Sin, 2017, 49(11):1029-1034. | 
																													
																							| [10] | Yi L, Huang X, Guo F, et al. Lipopolysaccharide induces human pulmonary micro-vascular endothelial apoptosis via the YAP signaling pathway[J]. Front Cell Infect Microbiol, 2016(6):133. | 
																													
																							| [11] | Wang G, Lu X, Dey P, et al. Targeting YAP-dependent MDSC infiltration impairs tumor progression[J]. Cancer Discov, 2016, 6(1): 80-95. | 
																													
																							| [12] | Fan Z, Xia H, Xu H, et al. Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma[J]. Biomed Pharmacother, 2018, 103:147-156. | 
																													
																							| [13] | Noce V, Battistelli C, Cozzolino AM, et al.YAP integrates the regulatory Snail/HNF4α circuitry controlling epithelial/hepatocyte differentiation[J]. Cell Death Dis, 2019, 10(10):768. | 
																													
																							| [14] | Guo X, Zhao Y, Yan H, et al. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages[J]. Genes Dev, 2017, 31(3):247-259. | 
																													
																							| [15] | Yang L, Zhang Y. Tumor-associated macrophages: from basic research to clinical application[J]. J Hematol Oncol, 2017, 10(1):58. | 
																													
																							| [16] | Biswas SK, Allavena P, Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions[J]. Semin Immunopathol, 2013, 35(5):585-600. | 
																													
																							| [17] | Yeung OW, Lo CM, Lin CC. et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma[J]. J Hepatol, 2015, 62(3):607-616. | 
																													
																							| [18] | Huang YJ, Yang CK, Wei PL, et al. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways[J]. J Hematol Oncol, 2017, 10(1):60. | 
																													
																							| [19] | Lee PC, Machner MP. The legionella effector kinase LegK7 hijacks the host Hippo pathway to promote infection[J]. Cell Host Microbe, 2018, 24(3):429-438. | 
																													
																							| [20] | Bouhlel MA, Derudas B, Rigamonti E, et al. PPAR gamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties[J]. Cell Metab, 2007, 6(2):137-143. |